![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Implantica Receives CE Mark for RefluxStop
Implantica Receives CE Mark for RefluxStop
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Implantica_Logo.gif?t=1534541742&width=430)
August 17, 2018
Medical technology company Implantica earned a CE Mark for its RefluxStop device, used for treating patients that suffer from acid reflux.
Implantica received the CE Mark based on results from a multi-center investigation that demonstrated its safety and effectiveness, and it may now market the device in the European Economic Area and Switzerland.
The device avoids potential complications that arise from compressing the food passageway — such as difficulty swallowing and inability to burp or vomit — treating gastroesophageal reflux disease without squeezing the passageway.
Upcoming Events
-
21Oct